Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
<h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsi...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2018
|
_version_ | 1797067904252903424 |
---|---|
author | Haskovic, M Derks, B Van Der Ploeg, L Trommelen, J Nyakayiru, J Van Loon, L Mackinnon, S Yue, W Peake, R Zha, L Demirbas, D Qi, W Huang, X Berry, G Achten, J Bierau, J Rubio-Gozalbo, M Coelho, A |
author_facet | Haskovic, M Derks, B Van Der Ploeg, L Trommelen, J Nyakayiru, J Van Loon, L Mackinnon, S Yue, W Peake, R Zha, L Demirbas, D Qi, W Huang, X Berry, G Achten, J Bierau, J Rubio-Gozalbo, M Coelho, A |
author_sort | Haskovic, M |
collection | OXFORD |
description | <h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsible for classic galactosemia have been described to give rise to variants with conformational abnormalities. This pathogenic mechanism is highly amenable to a therapeutic strategy based on chemical/pharmacological chaperones. Arginine, a chemical chaperone, has shown beneficial effect in other inherited metabolic disorders, as well as in a prokaryotic model of classic galactosemia.</p> <br/> <p>The p.Q188R mutation presents a high prevalence in the Caucasian population, making it a very clinically relevant mutation. This mutation gives rise to a protein with lower conformational stability and lower catalytic activity. The aim of this study is to assess the potential therapeutic role of arginine for this mutation.</p> <h4>Methods</h4> <p>Arginine aspartate administration to four patients with the p.Q188R/p.Q188R mutation, in vitro studies with three fibroblast cell lines derived from classic galactosemia patients as well as recombinant protein experiments were used to evaluate the effect of arginine in galactose metabolism. This study has been registered at https://clinicaltrials.gov (NCT03580122) on 09 July 2018. Retrospectively registered.</p> <h4>Results</h4> <p>Following a month of arginine administration, patients did not show a significant improvement of whole-body galactose oxidative capacity (p = 0.22), erythrocyte GALT activity (p = 0.87), urinary galactose (p = 0.52) and urinary galactitol levels (p =0.41). Patients’ fibroblasts exposed to arginine did not show changes in GALT activity. Thermal shift analysis of recombinant p.Q188R GALT protein in the presence of arginine did not exhibit a positive effect.</p> <h4>Conclusions</h4> <p>This short pilot study in four patients homozygous for the p.Q188R/p.Q188R mutation reveals that arginine has no potential therapeutic role for galactosemia patients homozygous for the p.Q188R mutation.</p> |
first_indexed | 2024-03-06T22:03:05Z |
format | Journal article |
id | oxford-uuid:4f44f3f2-92d0-4835-bb8f-e083515b6115 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T22:03:05Z |
publishDate | 2018 |
publisher | BioMed Central |
record_format | dspace |
spelling | oxford-uuid:4f44f3f2-92d0-4835-bb8f-e083515b61152022-03-26T16:06:04ZArginine does not rescue p.Q188R mutation deleterious effect in classic galactosemiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4f44f3f2-92d0-4835-bb8f-e083515b6115EnglishSymplectic Elements at OxfordBioMed Central2018Haskovic, MDerks, BVan Der Ploeg, LTrommelen, JNyakayiru, JVan Loon, LMackinnon, SYue, WPeake, RZha, LDemirbas, DQi, WHuang, XBerry, GAchten, JBierau, JRubio-Gozalbo, MCoelho, A <h4>Background</h4> <p>Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications.</p> <br/> <p>Many mutations in the GALT gene responsible for classic galactosemia have been described to give rise to variants with conformational abnormalities. This pathogenic mechanism is highly amenable to a therapeutic strategy based on chemical/pharmacological chaperones. Arginine, a chemical chaperone, has shown beneficial effect in other inherited metabolic disorders, as well as in a prokaryotic model of classic galactosemia.</p> <br/> <p>The p.Q188R mutation presents a high prevalence in the Caucasian population, making it a very clinically relevant mutation. This mutation gives rise to a protein with lower conformational stability and lower catalytic activity. The aim of this study is to assess the potential therapeutic role of arginine for this mutation.</p> <h4>Methods</h4> <p>Arginine aspartate administration to four patients with the p.Q188R/p.Q188R mutation, in vitro studies with three fibroblast cell lines derived from classic galactosemia patients as well as recombinant protein experiments were used to evaluate the effect of arginine in galactose metabolism. This study has been registered at https://clinicaltrials.gov (NCT03580122) on 09 July 2018. Retrospectively registered.</p> <h4>Results</h4> <p>Following a month of arginine administration, patients did not show a significant improvement of whole-body galactose oxidative capacity (p = 0.22), erythrocyte GALT activity (p = 0.87), urinary galactose (p = 0.52) and urinary galactitol levels (p =0.41). Patients’ fibroblasts exposed to arginine did not show changes in GALT activity. Thermal shift analysis of recombinant p.Q188R GALT protein in the presence of arginine did not exhibit a positive effect.</p> <h4>Conclusions</h4> <p>This short pilot study in four patients homozygous for the p.Q188R/p.Q188R mutation reveals that arginine has no potential therapeutic role for galactosemia patients homozygous for the p.Q188R mutation.</p> |
spellingShingle | Haskovic, M Derks, B Van Der Ploeg, L Trommelen, J Nyakayiru, J Van Loon, L Mackinnon, S Yue, W Peake, R Zha, L Demirbas, D Qi, W Huang, X Berry, G Achten, J Bierau, J Rubio-Gozalbo, M Coelho, A Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title | Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title_full | Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title_fullStr | Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title_full_unstemmed | Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title_short | Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia |
title_sort | arginine does not rescue p q188r mutation deleterious effect in classic galactosemia |
work_keys_str_mv | AT haskovicm argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT derksb argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT vanderploegl argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT trommelenj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT nyakayiruj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT vanloonl argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT mackinnons argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT yuew argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT peaker argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT zhal argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT demirbasd argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT qiw argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT huangx argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT berryg argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT achtenj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT bierauj argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT rubiogozalbom argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia AT coelhoa argininedoesnotrescuepq188rmutationdeleteriouseffectinclassicgalactosemia |